ATE37712T1 - -2-(2-hydroxy-4-(substituierte)phenyl) piperidine. - Google Patents

-2-(2-hydroxy-4-(substituierte)phenyl) piperidine.

Info

Publication number
ATE37712T1
ATE37712T1 AT84301635T AT84301635T ATE37712T1 AT E37712 T1 ATE37712 T1 AT E37712T1 AT 84301635 T AT84301635 T AT 84301635T AT 84301635 T AT84301635 T AT 84301635T AT E37712 T1 ATE37712 T1 AT E37712T1
Authority
AT
Austria
Prior art keywords
phenyl
alk2
alk1
piperidines
hydroxy
Prior art date
Application number
AT84301635T
Other languages
German (de)
English (en)
Inventor
Michael Ross Johnson
Lawrence Sherman Melvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE37712T1 publication Critical patent/ATE37712T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT84301635T 1983-03-14 1984-03-12 -2-(2-hydroxy-4-(substituierte)phenyl) piperidine. ATE37712T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/474,957 US4529732A (en) 1983-03-14 1983-03-14 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
EP84301635A EP0119087B1 (en) 1983-03-14 1984-03-12 2-(2-hydroxy-4-(substituted) phenyl) piperidines

Publications (1)

Publication Number Publication Date
ATE37712T1 true ATE37712T1 (de) 1988-10-15

Family

ID=23885667

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84301635T ATE37712T1 (de) 1983-03-14 1984-03-12 -2-(2-hydroxy-4-(substituierte)phenyl) piperidine.

Country Status (8)

Country Link
US (1) US4529732A (en, 2012)
EP (1) EP0119087B1 (en, 2012)
JP (1) JPS59176255A (en, 2012)
AT (1) ATE37712T1 (en, 2012)
DE (1) DE3474445D1 (en, 2012)
DK (1) DK113984A (en, 2012)
GR (1) GR81837B (en, 2012)
IE (1) IE57030B1 (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
FR2793246B1 (fr) * 1999-05-03 2001-06-29 Adir Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005536554A (ja) * 2002-08-23 2005-12-02 ユニバーシティ オブ コネチカット 新規なビフェニル及びビフェニル様カンナビノイド
WO2007127711A2 (en) * 2006-04-24 2007-11-08 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7618966B2 (en) 2006-04-24 2009-11-17 Allergan, Inc. Abnormal Cannabidiols as agents for lowering intraocular pressure
US7612101B2 (en) 2006-04-24 2009-11-03 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7718830B2 (en) 2006-04-24 2010-05-18 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
JP2025522912A (ja) * 2022-07-06 2025-07-17 ヴィヴィディオン セラピューティクス, インコーポレイテッド Wrnヘリカーゼ阻害剤を含む医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498431A (en) * 1945-06-13 1950-02-21 Hoffmann La Roche 2-and 4-homocyclyl substituted piperidines
US3067204A (en) * 1959-09-16 1962-12-04 Smith Kline French Lab 2, 2-dimethyl-6-phenylpiperidine derivatives
FR1288025A (fr) * 1960-02-08 1962-03-24 Boehringer & Soehne Gmbh Procédé de préparation de nouvelles piperidones-(4) substituées en position 1, 2, 6 ou de leurs sels
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
US4306097A (en) * 1977-09-13 1981-12-15 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines

Also Published As

Publication number Publication date
IE57030B1 (en) 1992-03-25
US4529732A (en) 1985-07-16
DK113984D0 (da) 1984-02-28
EP0119087B1 (en) 1988-10-05
GR81837B (en, 2012) 1984-12-12
JPS59176255A (ja) 1984-10-05
IE840624L (en) 1984-09-14
EP0119087A1 (en) 1984-09-19
JPS6237034B2 (en, 2012) 1987-08-10
DK113984A (da) 1984-09-15
DE3474445D1 (en) 1988-11-10

Similar Documents

Publication Publication Date Title
NO933452D0 (no) Et terapeutisk middel for parkinson's sykdom
ATE219077T1 (de) Endothelin antagoniste
MX9306831A (es) Nuevos compuestos heterociclicos.
NL180206B (nl) Verbinding en geneesmiddel met analgetische werking.
GB2061272B (en) Morpholine derivatives
NO932607D0 (no) Piperidinderivater og anvendelse av disse
ATE37712T1 (de) -2-(2-hydroxy-4-(substituierte)phenyl) piperidine.
MY106314A (en) New tetrazole derivatives, process for their preparation and their use
EG16546A (en) Therapeutic agents
SE8904127D0 (sv) New biocyclic amino-substituted compounds
ES8707226A1 (es) Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol
NO861630L (no) Karbapenemderivater og fremgangsmaate til fremstilling derav.
NO941084L (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
DE3666223D1 (en) Anticonvulsant agents
NO944577L (no) Hemming av effekten av amyloidogene proteiner
ES536218A0 (es) Procedimiento para la obtencion de derivados de hidroxietilazoliloxima
ES468586A1 (es) Procedimiento para la preparacion de nuevas piridobenzodia- zepinonas.
DK347387A (da) Amidderivater
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
NZ223664A (en) 2,3-dihydro-3-phenyl-2-oxo-benzofuranylacetic acid amide derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee